Data/Analytics


Leadership Exchange: Social Listening

Leadership Exchange: Social Listening

Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.

The Era of DTC Diagnostics, Diagnosis and Drug Development Is Here

The Era of DTC Diagnostics, Diagnosis and Drug Development Is Here

Despite conventional wisdom that the 23andMe business breakthrough is the direct-to-consumer model, it's also the consolidation of genetic testing, diagnosis and drug development that has the potential to change the industry.

Five things for pharma marketers to know: Thursday, December 3, 2015

Five things for pharma marketers to know: Thursday, December 3, 2015

Healthcare spending rose in 2014; Publicis reorganizes its agency network; proposed New Jersey bill would punish drugmakers that move abroad

Data Management: Not If, But When

Data Management: Not If, But When

Healthcare may seem to have been unscarred by the ongoing rash of high-profile cyber-attacks, at least compared with retail and financial organizations. But to hear security pros tell it, the industry is increasingly finding itself as much of a target as companies in other sectors—if not more of one. Karen Epper Hoffman surveys the potential damage

IMS Health: Drug spend will steadily rise through 2020

IMS Health: Drug spend will steadily rise through 2020

Specialty medicines will keep drug spend trending upward through the next five years.

Late-Phase Diabetes Research: Time To Get Onboard

Late-Phase Diabetes Research: Time To Get Onboard

If more physicians begin participating in late-phase research efforts—and work to educate patients about these opportunities—we can expect new innovations in treatment solutions to come more quickly to market.

How IBM's cognitive computing platform might help make healthcare smarter

How IBM's cognitive computing platform might help make healthcare smarter

Soon, IBM says, Watson will be used by one particular pharma company to create a website where, once a drug is prescribed, patients can ask questions in their own words and the website will provide answers in near real-time.

Is pharma's access to physicians decreasing or increasing?

Is pharma's access to physicians decreasing or increasing?

A pair of surveys paint a complicated picture of what direction pharma access to healthcare providers is going.

Drugmakers spend too much on marketing: Kaiser poll

Drugmakers spend too much on marketing: Kaiser poll

The public said drugmakers spend too much money on marketing to doctors and patients

Pharma's acceptance of transparency programs matures as reporting becomes global

Pharma's acceptance of transparency programs matures as reporting becomes global

Initiatives in Europe follow the US example when it comes to requiring manufacturers to report information about financial relationships with physicians.